Bortezomib

Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.

Bortezomib ((1R,2S)-Bortezomib)

Bortezomib D8

Bortezomib – API

 

White to Off-White Solid

SKU: ec3070ff4db1 Category: Tag:

Notice: id was called incorrectly. Product properties should not be accessed directly. Backtrace: require('wp-blog-header.php'), require_once('wp-includes/template-loader.php'), include('/plugins/woocommerce/templates/single-product.php'), wc_get_template_part, load_template, require('/plugins/woocommerce/templates/content-single-product.php'), do_action('woocommerce_after_single_product_summary'), WP_Hook->do_action, WP_Hook->apply_filters, woocommerce_output_related_products, woocommerce_related_products, wc_get_template, include('/themes/stout/templates/woocommerce/single-product/related.php'), WC_Abstract_Legacy_Product->__get, wc_doing_it_wrong Please see Debugging in WordPress for more information. (This message was added in version 3.0.) in /var/www/wp-includes/functions.php on line 5313